Literature DB >> 6724255

Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption.

W G Hardison, S M Grundy.   

Abstract

Six male subjects with normal gastroenterologic function were studied to determine the effects of ursodeoxycholic (15 mg/kg X day) and tauroursodeoxycholic (20 mg/kg X day) acid feeding on bile acid synthesis and cholesterol absorption. Each bile acid was fed for 1 mo and withheld for the next month. Subjects remained on a metabolic ward and consumed a constant diet of 500 mg of cholesterol mixed with solid and liquid formulas. Before the study started, each subject received 50 muCi of [4-14C]cholesterol intravenously. During the study, stools were collected for the determination of 24-h fecal acidic and neutral sterol excretion, and blood was drawn twice weekly for determination of serum cholesterol specific activity. At the end of each month an intestinal perfusion study was performed to measure total bile acid pool size and hourly biliary secretion rates of cholesterol, phospholipid, and bile acid. From these data, the percentage of cholesterol absorption and total endogenous bile acid synthesis could be calculated. Neither ursodeoxycholic nor tauroursodeoxycholic acid feeding decreased endogenous bile acid synthesis. During bile acid feeding periods, the percentage of cholesterol absorption was decreased.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724255

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

2.  Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress.

Authors:  Robert M Restaino; Shekhar H Deo; Alan R Parrish; Paul J Fadel; Jaume Padilla
Journal:  Exp Physiol       Date:  2017-01-10       Impact factor: 2.969

3.  Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.

Authors:  J Cotting; M J Lentze; J Reichen
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

4.  Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.

Authors:  B Combes; R L Carithers; W C Maddrey; S Munoz; G Garcia-Tsao; G F Bonner; J L Boyer; V A Luketic; M L Shiffman; M G Peters; H White; R K Zetterman; R Risser; S S Rossi; A F Hofmann
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.

Authors:  G Mazzella; P Parini; F Bazzoli; N Villanova; D Festi; R Aldini; A Roda; A Cipolla; C Polimeni; D Tonelli
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.

Authors:  S Okamoto; K Nakano; K Kosahara; M Kishinaka; H Oda; H Ichimiya; K Chijiiwa; S Kuroki
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

7.  Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Authors:  Lauren K Walsh; Robert M Restaino; Martha Neuringer; Camila Manrique; Jaume Padilla
Journal:  Clin Sci (Lond)       Date:  2016-08-08       Impact factor: 6.124

8.  Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease.

Authors:  A Lapidus; K Einarsson
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.

Authors:  S Eusufzai; S Ericsson; T Cederlund; K Einarsson; B Angelin
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

10.  Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.

Authors:  Y Chretien; R Poupon; M F Gherardt; O Chazouilleres; D Labbe; A Myara; F Trivin
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.